Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2010
12/28/2010US7858334 Using sterospecific carboxylesterase variant for bioremediation of pyrethroids; eliminating or reducing the concentration of a pyrethroid pesticide in a sample
12/28/2010US7858333 drug screening against tumors, such as blood cancers, using inhibition of FLT3/ITD function as an index; acute myeloid leukemia
12/28/2010US7858329 determining whether a treatment of a disorder with an HDAC inhibitor is to be started/continued or not by determining the level of histone acetylation in the sample using an antibody capable of binding to acetylated histone
12/28/2010US7858323 Phage microarray profiling of the humoral response to disease
12/28/2010US7858321 Methods and apparatus for conducting multiple measurements on a sample
12/28/2010US7858320 Method, substances and kits for labeling population of RNA and other substances containing vicinal diols
12/28/2010US7858319 Monitoring human response to antiviral agents; obtain tissue sample, extract nucleotide sequences, detect tumor necrosis factor genotype, presence of genotype indicates sensitivity to viricide; treating a male Caucasian human in need of treatment with abacavir
12/28/2010US7858318 Methods and compositions for vitamin K epoxide reductase
12/28/2010US7858317 Diagnosing cellular proliferative disorder by detecting mutations in retinoic acid receptor beta (RAR beta), estrogen receptor (ER), and cyclin D2 gene sequences; DNA methylation defects; modification methylases; breast cancer
12/28/2010US7858316 Testing a compound for its ability to interupt a tmRNA structural domain selected from a H2 helix, a H5 helix, a PK1 pseudoknot, a PK2 pseudoknot, a PK3 pseudoknot or a PK4 pseudoknot to identify a drug candidate for treating a bacterial infection
12/28/2010US7858315 Probe, probe set, probe carrier, and testing method
12/28/2010US7858314 for detecting a nucleic acid of Trichophyton tonsurans which is a pathogenic fungus with a high degree of accuracy even for an analyte containing DNAs of a plurality of fungi with a less cross-contamination level
12/28/2010US7858313 Method of evaluating drug sensitivity by analyzing GIRK channel genes
12/28/2010US7858312 Method of treating bladder and lower urinary tract syndromes
12/28/2010US7858311 Polymerase-nucleic acid complex comprising anchor which irreversibly associates target nucleotide with multimeric complex for use as tool in enhancing polymerase processivity in DNA sequencing; detecting incorporation of a labeled nucleotide triphosphate onto the growing end of a primer nucleic acid
12/28/2010US7858310 detection of the taura syndrome virus (TSV); kits; aquaculture
12/28/2010US7858309 identifying a patient suffering from active relapsing remitting multiple sclerosis; comparing amount of XIAP and HIAP-2 gene expression levels in peripheral blood mononuclear (PBMN) cells with control
12/28/2010US7858308 Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
12/28/2010US7858307 Light transmitted assay beads
12/28/2010US7858306 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (HSD3B1; also called HSD3B and HSDB3); allozymes
12/28/2010US7858305 Controllably flowing a solution of nucleic acid over a first substrate to promote stretching and transferring the stretched molecule to a second substrate
12/28/2010US7858304 Gene expression profiling in biopsied tumor tissues
12/28/2010US7858303 obtaining a DNA sample from a patient, genotyping for the presence of the minor allele of single nucleotide polymorphisms rs6476643 or rs2182317; analyzing invasive breast cancer susceptibility or resistance
12/28/2010US7858302 Real time nucleic acid detection allows for the qualitative or quantitative detection or determination of single-stranded or double-stranded nucleic acids of interest in a sample; for removing a portion of a homopolymeric sequence from an analyte or library of analytes
12/28/2010US7858301 hybridization-mediated multiplexed analysis of polymorphisms under conditions permitting competitive hybridization
12/28/2010US7858300 Methods and compositions to evaluate antibody treatment response
12/28/2010US7858299 bacteriophage tail proteins capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+
12/28/2010US7858298 Contacting with monoclonal antibody which binds to chemokine receptor; blocks fusion and inhibits activation of inflammatory response; inhibiting fusion of HIV-1 to CD4+ cells
12/28/2010US7858297 Chemokine-binding protein and methods of use
12/28/2010US7858100 novel rod-shaped pleiomorphic non-motile Gram-negative bacterium causing a new deadly disease in fish; kit for the detection of antibodies reactive with the bacterium
12/28/2010US7858099 Method for inducing an immunological response in an animal
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/28/2010US7858090 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
12/28/2010US7858034 an layout of cells comprising transistors, connected to a power source
12/23/2010WO2010148332A2 Systems and methods for analyzing a particulate
12/23/2010WO2010148323A2 Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
12/23/2010WO2010148212A2 Short telomere length on chromosome 9p is strongly associated with breast cancer risk
12/23/2010WO2010148036A1 Identification and assessment of memory modulating compounds
12/23/2010WO2010147918A2 Detection of acid-producing bacteria
12/23/2010WO2010147848A2 Kits and methods for selective amplification and detection of nucleic acid targets
12/23/2010WO2010147714A1 Autism-associated biomarkers and uses thereof
12/23/2010WO2010147673A2 Single-dna molecule nanomotor regulated by photons
12/23/2010WO2010147654A2 Improved methods for forensic dna quantitation
12/23/2010WO2010147601A1 Use of methylation status of mint loci as a marker for rectal cancer
12/23/2010WO2010147561A1 Method for conducting multiple reactions in a single reaction tube
12/23/2010WO2010147489A1 Methods and compositions for assessment of pulmonary function and disorders
12/23/2010WO2010147467A2 Novel tomato plants
12/23/2010WO2010147452A1 A method for the assessment of cancer in a biological sample obtained from a subject
12/23/2010WO2010147372A2 Primer and probe for detecting malaria plasmodium and detection method using same
12/23/2010WO2010147273A2 Method for screening agents to treat reproductive function disorders caused by alcohol exposure
12/23/2010WO2010147196A1 Protein having novel prenylation enzyme activity and gene encoding same
12/23/2010WO2010147167A1 Method for positioning of probe in microarray
12/23/2010WO2010147138A1 Gene encoding fatty acid elongase, and use thereof
12/23/2010WO2010147117A1 Peptide and use thereof
12/23/2010WO2010146830A1 Method and kit for detection of guaiacol-producing bacterium
12/23/2010WO2010146758A1 Fluorescent analysis method
12/23/2010WO2010146613A1 Method for detection and diagnostic method of hmga1 gene polymorphism
12/23/2010WO2010146437A1 Screening methods of genetic polymorphisms associated to the immune response for the evaluation of athletic predisposition and relative kits
12/23/2010WO2010146357A1 Oil palm and processes for producing it
12/23/2010WO2010146349A1 Stem accelerated isothermal nucleic acid amplification technology
12/23/2010WO2010146339A1 Nucleic acid detection
12/23/2010WO2010146214A2 Method for evaluating the athletic capabilities of a subject
12/23/2010WO2010146164A1 Fluorogenic peptidase substrate
12/23/2010WO2010146064A1 Diagnostical use of peroxiredoxin 4
12/23/2010WO2010146026A1 Improvement of low-biomass soil dna/rna extraction yield and quality
12/23/2010WO2010145839A2 Polynucleotides for medical use
12/23/2010WO2010145796A2 Biomarkers and methods for determining efficacy of anti-egfr antibodies in cancer therapy
12/23/2010WO2010145754A1 Method for isolating cells
12/23/2010WO2010145696A1 Methods for detecting the presence or absence of blood
12/23/2010WO2010145035A1 Renal cell carcinoma biomarkers
12/23/2010WO2010145000A1 Biomarker of sarcomas
12/23/2010WO2010144965A1 Viral assay
12/23/2010WO2010144946A1 Method of determining response to treatment with immunomodulatory composition
12/23/2010WO2010127342A8 Method of preparing autologous cells and method of use for therapy
12/23/2010WO2010117212A3 Cell sensor, and monitoring method using same for the real-time monitoring of cell capacitance
12/23/2010WO2010117198A3 Production process of gender-specific serum and biomarker using the serum
12/23/2010WO2010103388A8 Methods using axl as a biomarker of epithelial-to-mesnchymal transition
12/23/2010WO2010099211A3 Compositions and methods for diagnosing and preventing spontaneous preterm birth
12/23/2010WO2010081001A3 Recurrent gene fusions in cancer
12/23/2010WO2009099378A8 Selection of rna-aptamers as anti-malaria agents
12/23/2010US20100325751 Tomato plants that exhibit resistance to botrytis cinerea
12/23/2010US20100325750 Major QTLS Conferring Resistance Of Corn To Fijivirus
12/23/2010US20100325743 Marks as modifiers of the p53 pathway and methods of use
12/23/2010US20100325742 Animal Model Based on Targeted Apoptosis for the Study of Genetic Diseases Such as Parkinson's Disease
12/23/2010US20100324277 Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation
12/23/2010US20100324268 Multi-oligomeric or multi--polymeric compositions comprising labeled moieties and binding partners
12/23/2010US20100324154 Assessing susceptibility to vascular disorders
12/23/2010US20100324125 Proteins derived from white spot syndrome virus and uses thereof
12/23/2010US20100324123 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches
12/23/2010US20100324122 Modulation of sglt2 expression
12/23/2010US20100324121 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
12/23/2010US20100324119 Reducing irf4, dusp22, or flj43663 polypeptide expression
12/23/2010US20100324114 Methods and kits to detect hereditary angioedema type III
12/23/2010US20100324112 Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer
12/23/2010US20100324094 Conformationally Restrained Epothilone Analogues as Anti-Leukemic Agents
12/23/2010US20100323979 Methods and compositions for inhibiting proliferation of aneuploid cells
12/23/2010US20100323922 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
12/23/2010US20100323921 Molecular prognostic signature for predicting breast cancer metastasis, and uses thereof
12/23/2010US20100323915 Porous Substrate Plates And The Use Thereof
12/23/2010US20100323912 Real-time analytical methods and systems
1 ... 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 ... 3003